Evidence map›Paper›PMID 21399989›Full record

ArticleJournal of the Association for Research in Otolaryngology : JARO2011

Scleraxis is required for differentiation of the stapedius and tensor tympani tendons of the middle ear.

Lingyan Wang, Chris S Bresee, Han Jiang, Wenxuan He, Tianying Ren, Ronen Schweitzer, John V Brigande

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the Association for Research in Otolaryngology : JARO, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. The impact of Drew Noden's work on our understanding of craniofacial musculoskeletal integration.Developmental dynamics : an official publication of the American Association of Anatomists · 2022
    Review
  5. A requirement for Fgfr2 in middle ear development.Genesis (New York, N.Y. : 2000) · 2019
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lingyan WangOregon Hearing Research Center, Oregon Health & Science University, Portland, USA. wangli@ohsu.edu
Chris S Bresee
Han Jiang
Wenxuan He
Tianying Ren
Ronen Schweitzer
John V Brigande
Oregon Health & Science University · USShriners Hospitals for Children - Portland · US

Funding

PORTLAND AREA COMMUNICATION RESEARCH CORE CENTERP30DC005983 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI NUTTALL, ALFRED L · 2003 to 2017
$9.0M
Experimental study of the cochlear amplifierR01DC004554 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI REN, TIANYING · 2001 to 2021
$7.7M
Molecular Embryology of the Mammalian Inner EarR01DC008595 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI BRIGANDE, JOHN VINCENT · 2007 to 2018
$4.0M
REGULATION OF TENDON INDUCTION AND FORMATION BY TGFbeta SIGNALINGR01AR055640 · NIAMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI SCHWEITZER, RONEN · 2007 to 2011
$1.6M
NIAMS NIH HHS R01 AR055640NIDCD NIH HHS DC R01 008595NIDCD NIH HHS DC R01 008595-03S2NIDCD NIH HHS P30 DC005983NIDCD NIH HHS R01 DC004554NIDCD NIH HHS R01 DC008595NIDCD NIH HHS R01 DC04554
6 · The paper itself

Abstract

Scleraxis (Scx) is a basic helix-loop-helix transcription factor expressed in tendon and ligament progenitor cells and the differentiated cells within these connective tissues in the axial and appendicular skeleton. Unexpectedly, we found expression of the Scx transgenic reporter mouse, Scx-GFP, in interdental cells, sensory hair cells, and cochlear supporting cells at embryonic day 18.5 (E18.5). We evaluated Scx-null mice to gain insight into the function of Scx in the inner ear. Paradoxical hearing loss was detected in Scx-nulls, with ~50% of the mutants presenting elevated auditory thresholds. However, Scx-null mice have no obvious, gross alterations in cochlear morphology or cellular patterning. Moreover, we show that the elevated auditory thresholds correlate with middle ear infection. Laser interferometric measurement of sound-induced malleal movements in the infected Scx-nulls demonstrates increased impedance of the middle ear that accounts for the hearing loss observed. The vertebrate middle ear transmits vibrations of the tympanic membrane to the cochlea. The tensor tympani and stapedius muscles insert into the malleus and stapes via distinct tendons and mediate the middle ear muscle reflex that in part protects the inner ear from noise-induced damage. Nothing, however, is known about the development and function of these tendons. Scx is expressed in tendon progenitors at E14.5 and differentiated tenocytes of the stapedius and tensor tympani tendons at E16.5-18.5. Scx-nulls have dramatically shorter stapedius and tensor tympani tendons with altered extracellular matrix consistent with abnormal differentiation in which condensed tendon progenitors are inefficiently incorporated into the elongating tendons. Scx-GFP is the first transgenic reporter that identifies middle ear tendon lineages from the time of their formation through complete tendon maturation. Scx-null is the first genetically defined mouse model for abnormal middle ear tendon differentiation. Scx mouse models will facilitate studies of tendon and muscle formation and function in the middle ear.

Indexed as

AnimalsAuditory ThresholdBasic Helix-Loop-Helix ProteinsBiomechanical PhenomenaCell DifferentiationEar, MiddleFemaleHearing LossMaleMiceMice, KnockoutMice, TransgenicModels, AnimalMorphogenesisOrgan of CortiStapediusBasic Helix-Loop-Helix ProteinsScx protein, mouse

Identifiers

PMID21399989
PMCPMC3123444
OpenAlexW1988417426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.